ÂÜÀòÂÒÂ×

Rob Lozuk is a commercial, operations and strategy leader in the global healthcare industry who serves as Chief Executive Officer, President, Secretary and member of the Board of Directors at Syantra Inc. (2023–Present). They are founder and Chief Executive Officer of ZEN Diagnostics (2017–Present) and serve on the boards of Limmi (2023–Present) and Gaia Medical Institute (2022–Present); their education includes UC Santa Barbara (present). Lozuk previously served as Chief Business Officer at Cardea Bio Inc. (2019–2023; acquired by Paragraf), was a member of the board at National Cardiac, Inc. (2021–2023), was President of Specific Diagnostics (2016–2017; acquired by bioMerieux), and held senior commercial and business development roles at Sequenom, Inc. (Vice President and Senior Vice President, 2012–2015; acquired by Lab Corp), Thermo Fisher Scientific (Director roles, 2010–2012) and Dako (Global Product Manager, 2000–2005). They have expertise in corporate development, business development, fundraising, process improvement and team building.